Cargando…
Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
Data generated over nearly two decades clearly demonstrate the importance of epigenetic modifications and mechanisms in the pathogenesis of type 2 diabetes. However, the role of pharmacoepigenetics in type 2 diabetes is less well established. The field of pharmacoepigenetics covers epigenetic biomar...
Autor principal: | Ling, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522755/ https://www.ncbi.nlm.nih.gov/pubmed/35307762 http://dx.doi.org/10.1007/s00125-022-05681-x |
Ejemplares similares
-
Pharmacoepigenetics in Heart Failure
por: Mateo Leach, Irene, et al.
Publicado: (2010) -
Promises and challenges in pharmacoepigenetics
por: Smith, Delaney A., et al.
Publicado: (2023) -
Editorial: Molecular Targeted Therapy in Oncology: Lessons From Pharmacogenetics and Pharmacoepigenetics
por: Imani, Saber, et al.
Publicado: (2022) -
Rapid Collection of Biospecimens by Automated Identification of Patients Eligible for Pharmacoepigenetic Studies
por: Sun, Yan V., et al.
Publicado: (2013) -
Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
por: Dixit, Vishwa Deep
Publicado: (2013)